Impossibility to eliminate observer effect in the assessment of adherence in clinical trials

PURPOSE: To utilize the Travoprost Dosing Aid (DA) in the assessment of patient medication adherence, while also determining whether or not altering the functionality of the DA in three randomized subject groups can reduce observer effect. METHODS: Forty-five subjects were randomized into three grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Myers, Jonathan S, Fudemberg, Scott J, Fintelmann, Robert E, Hark, Lisa A, Khanna, Nitasha, Leiby, Benjamin E, Waisbourd, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087773/
https://www.ncbi.nlm.nih.gov/pubmed/27822015
http://dx.doi.org/10.2147/PPA.S114746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087773/
https://www.ncbi.nlm.nih.gov/pubmed/27822015
http://dx.doi.org/10.2147/PPA.S114746

Ejemplares similares